Find the Right Market Report

Search thousands of industry reports, market insights, and research studies in one place.

Not sure where to start? Try one of these:
Explore healthcare market intelligence and industry insights
Towards Healthcare

Pre-Clinical Scientific Research Medical Device Companies, Corporate Growth and Development Strategy

Date : 09 March 2026

Top Vendors and Their Offerings in the Pre-Clinical Scientific Research Medical Device Market

Pre-Clinical Scientific Research Medical Device Market Companies are Charles Rive Laboratories, Eurofins Scientific, WuXi AppTec, SGS SA, ICON plc, IQVIA

Companies Headquarters Pre-clinical Scientific Research Medical Device Services
Charles Rive Laboratories Massachusetts, U.S. Preclinical research and safety assessments
Eurofins Scientific Luxembourg, Europe Advanced analytical testing
WuXi AppTec Shanghai, China Integrated R&D services
SGS SA Geneva, Switzerland Multidisciplinary validation and high-quality control
ICON plc  Dublin, Ireland Comprehensive preclinical consulting and automated clinical research solutions
IQVIA Durham, North Carolina AI and advanced analytics
NAMSA Northwood, Ohio End-to-end medical device development services
Intertek Group London, UK Mechanical and electrical testing
Medpace Cincinnati, Ohio Integrated medical expertise and regulatory guidance
Veranex  Raleigh, North Carolina Clinical and regulatory expertise

Market Value Chain Analysis

R&D

  • The R&D of the pre-clinical scientific research medical device focuses on the integration of AI and machine learning and the development of advanced biological models.
  • Key players: Charles Rive Laboratories, Eurofins Scientific, SGS SA.

Clinical Trials and Regulatory Approvals

  • The biological performance, safety, and effectiveness are evaluated in the clinical trials and regulatory approvals of the pre-clinical scientific research medical device.
  • Key players: SGS, NAMSA, Eurofins Scientific.

Patient Support and Services

  • Home-based clinical support, digital engagement platforms, and travel and lodging concierge services are provided in the patient support and services of the pre-clinical scientific research medical device.
  • Key players: IQVIA, ProPharma, ICON plc.

Market Growth

The global pre-clinical scientific research medical device market size was estimated at USD 25.04 billion in 2025 and is predicted to increase from USD 26.67 billion in 2026 to approximately USD 47 billion by 2035, expanding at a CAGR of 6.5% from 2026 to 2035.

Pre-Clinical Scientific Research Medical Device Market Size is USD 26.67 Billion in 2026.

What are the Recent Developments in the Market?

  • In January 2026, a successful acquisition of Labcrop, offering innovative and comprehensive laboratory services, by NAMSA, which us leader in medical device testing, preclinical and clinical services, and regulatory consulting, was announced, where the Early Development medical device testing business of Labcrop will support the core areas of preclinical drug development and chemical testing of NAMSA.
  • In July 2025, with a strategic supply and licensing agreement between MH3D and the Science and Technology Facilities Council (STFC) of the UK, the first MH3D systems were launched. This collaboration enables the integration of the next-generation imaging platforms of MH3D with the hyperspectral imaging technology of STFC to offer pre-clinical research applications.

Your complete Pre-Clinical Scientific Research Medical Device Market control center is just one click away - Access the Dashboard

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.

Talk to an Analyst Contact Sales